CMS Grants MIRODERM® Biologic Wound Matrix with HCPCS Code Q-4175

The U.S. Centers for Medicare and Medicaid Services (CMS) has granted a HCPCS code (healthcare common procedure coding system) for MIRODERM® Biologic Wound Matrix, a non-crosslinked acellular wound matrices derived from porcine liver and indicated for the management of wounds including: partial and full thickness wounds; venous and diabetic ulcers; surgical and trauma wounds among others.  A HCPCS code is a required for reimbursement in the CMS and other health insurance program systems.

Miromatrix Medical Inc is a biotechnology company engaged in the development of fully biological human organs to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization/recellularization technology, as well as organ-derived biological products for soft tissue reinforcement and advanced wound care.